Volume 2, Issue 1 (6-2016)                   Iran J Neurosurg 2016, 2(1): 19-21 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mehrazin M, Mirfallah R, Bokaei H, Sadr-Hosseini M. Outcome of Transphenoid Surgery for Corticotroph Pituitary Tumors. Iran J Neurosurg. 2016; 2 (1) :19-21
URL: http://irjns.org/article-1-33-en.html
1- MD, Neurosurgeon, Professor of Neurosurgery, TUMS, Shariati Hospital, Tehran, Iran. , Mehrazin@yahoo.com
2- MD, Neurosurgeon, Arad Hospital, Tehran, Iran
3- MD, ENT Surgeon, Arad Hospital, Tehran, Iran
4- MD, ENT Surgeon, Associate Professor of ENT Surgery, TUMS, Imam Khomeini Hospital, Tehran, Iran
Abstract:   (4271 Views)

Background & Importance: The aim of this study was to demonstrate the result of transsphenoid microsurgery for Cushing disease in our center and comparing the results in details with other articles, to achieve the best decision for patients management in future.
Case Presentation: Between 1991 to 2015, 50 patients suffering from Cushing disease were operated. Before operation, endocrine tests and neuroimaging examinations were done for all patients and all of them were operated via transsphenoid approach. They were followed up in clinic with endocrine tests and imaging in regular intervals. During this study, 50 Cushing cases including 47 primary and three secondary tumors were operated. Thirty four (68%) tumors were microadenoma and 16 (32%) macroadenoma. A patient died due to postoperative fulminant meningitis (mortality=2%). Mean of follow-up was five years. Overall, 40 (80%) patients had remission after operation and 9 (18%) patients achieved no remission, three of them had macroadenoma and six microadenoma. During follow-up period, three (6%) patients had recurrence which needed second operation. In secondary tumor and in macroadenoma with cavernous sinus involvement, the
result was not good (33% and 0% remission, respectively).
Conclusion: Transsphenoid surgery is a safe and effective first choice method to manage Cushing disease compared to other treatment modalities. In recurrent or resistant cases, other modalities could help to manage patients.

Full Text [PDF 295 kb]   (1120 Downloads) |   |   Full Text (HTML)  (930 Views)  
Type of Study: Case report | Subject: Gamma Knife Radiosurgery

1. Winn HR. Youmans neurological surgery. sixth ed.Philadelphia:Elsesevier Saunders;2011.
2. Quinones-Hinojosa A. Schmidek and Sweet: Operative Neurosurgical Techniques: Indications, Methods and Results (Expert Consult-Online and Print). Elsevier Health Sciences; 2012.
3. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. New England Journal of Medicine. 1991;325(13):897-905. [DOI:10.1056/NEJM199109263251301] [PMID]
4. Laws ER, Lanzino G. Transsphenoidal surgery. First ed: Philadelphia:Elsesevier Saunders;2010
5. Fomekong E, Maiter D, Grandin C, Raftopoulos C. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clinical Neurology and Neurosurgery. 2009;111(5):442-9. [DOI:10.1016/j.clineuro.2008.12.011] [PMID]
6. Dehdashti AR, Gentili F. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique. Neurosurgical Focus. 2007;23(3):1-8. [DOI:10.3171/foc.2007.23.3.11] [PMID]
7. Blevins Jr LS, Christy JH, Khajavi M, Tindall GT. Outcomes of Therapy for Cushing's Disease due to Adrenocorticotropin-Secreting Pituitary Macroadenomas 1. The Journal of Clinical Endocrinology & Metabolism. 1998;83(1):63-7. https://doi.org/10.1210/jc.83.1.63 [DOI:10.1210/jcem.83.1.4525]
8. Shimon I, Ram Z, Cohen ZR, Hadani M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery. 2002;51(1):57-62. [DOI:10.1097/00006123-200207000-00008] [PMID]
9. Hammer GD, Tyrrell JB, Lamborn KR, Applebury CB, Hannegan ET, Bell S, et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. The Journal of Clinical Endocrinology & Metabolism. 2004;89(12):6348-57. [DOI:10.1210/jc.2003-032180] [PMID]
10. Hoffman BM,Hlavac M, Martinez R,Buchfelder M,Muller OA, Fahlbusch R. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. Journal of Neurosurgery 2008;108(1):9-18. [DOI:10.3171/JNS/2008/108/01/0009] [PMID]
11. Kelly DF. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome. Neurosurgical Focus. 2007;23(3):1-6. [DOI:10.3171/foc.2007.23.3.7] [PMID]
12. Wagenmakers MA, Boogaarts HD, Roerink SH, Timmers HJ, Stikkelbroeck NM, Smit JW, et al. Endoscopic transsphenoidal pituitary surgery: a good and safe primary treatment option for Cushing's disease, even in case of macroadenomas or invasive adenomas. European Journal of Endocrinology. 2013;169(3):329-37. [DOI:10.1530/EJE-13-0325] [PMID]
13. Dimopoulou C, Schopohl J, Rachinger W, Buchfelder M, Honegger J, Reincke M, et al. Long-term remission and recurrence rates after first and second transsphenoidal surgery for Cushing's disease: care reality in the Munich Metropolitan Region. European Journal of Endocrinology. 2014;170(2):283-92. [DOI:10.1530/EJE-13-0634] [PMID]
14. Kuo CH, Yen YS, Wu JC, Chen YC, Huvang WC, Chenq H. Primary endoscopic Trans-nasal Trans-sphenoidal surgery for Magnetic Resonance Image-Positive Cushing's disease: Outcomes of a series over 14 years. World Neurosurgery. 2015;(15):492-3

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Iranian Journal of Neurosurgery

Designed & Developed by : Yektaweb